Literature DB >> 24893954

Mild cognitive impairment diagnosed with the new DSM-5 criteria: prevalence and associations with non-cognitive psychopathology.

R Lopez-Anton1, J Santabárbara, C De-la-Cámara, P Gracia-García, E Lobo, G Marcos, G Pirez, P Saz, J M Haro, L Rodríguez-Mañas, P J Modrego, M E Dewey, A Lobo.   

Abstract

OBJECTIVE: To contrast the prevalence of mild cognitive impairment (MCI) as diagnosed using DSM-5 criteria (DSM5-MCI) with MCI as diagnosed using Petersen's criteria (P-MCI) and to explore the association of both with non-cognitive psychopathological symptoms (NCPS).
METHOD: A two-phase epidemiological screening was implemented in a population-based sample of individuals aged 55+ (n = 4803). The Geriatric Mental State (GMS) was the main psychopathological instrument used, and AGECAT was used to make psychiatric diagnoses. Research psychiatrists diagnosed DSM5-MCI and P-MCI using operational criteria. Logistic regression models were then used to investigate the association of MCI with anxiety and depression and with NCPS.
RESULTS: Weighted prevalence of DSM5-MCI and P-MCI was, respectively, 3.72% and 7.93% for the aged 65+. NCPS were common in both MCI categories, but negative-type symptoms such as 'anergia' and 'observed slowness' were considerably more frequent among persons with DSM5-MCI. Anxiety and depression diagnostic categories were associated with both P-MCI and DSM5-MCI, but affective-type symptoms were mainly associated with P-MCI. Some negative-type symptoms were inversely associated with P-MCI, and no association was observed with DSM5-MCI.
CONCLUSION: The prevalence of DSM5-MCI was half that of P-MCI. Negative-type NCPS were more frequently and typically associated with DSM5-MCI.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DSM-5; community study; mild cognitive impairment; non-cognitive psychopathological symptoms; prevalence

Mesh:

Year:  2014        PMID: 24893954     DOI: 10.1111/acps.12297

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  11 in total

1.  Staging cognitive impairment and incidence of dementia.

Authors:  J Santabárbara; R Lopez-Anton; P Gracia-García; C De-la-Cámara; D Vaquero-Puyuelo; E Lobo; G Marcos; L Salvador-Carulla; T Palomo; N Sartorius; A Lobo
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-15       Impact factor: 6.892

2.  Barriers to Mental Health Treatment in Rural Older Adults.

Authors:  Gretchen A Brenes; Suzanne C Danhauer; Mary F Lyles; Patricia E Hogan; Michael E Miller
Journal:  Am J Geriatr Psychiatry       Date:  2015-06-17       Impact factor: 4.105

3.  Rationale and Design of the National Neuropsychology Network.

Authors:  David W Loring; Russell M Bauer; Lucia Cavanagh; Daniel L Drane; Laura Glass Umfleet; Dustin Wahlstrom; Fiona Whelan; Keith F Widaman; Robert M Bilder; Kristen D Enriquez; Steven P Reise; KuoChung Shih
Journal:  J Int Neuropsychol Soc       Date:  2021-03-04       Impact factor: 2.892

Review 4.  Mild Neurocognitive Disorder: An Old Wine in a New Bottle.

Authors:  Gorazd B Stokin; Janina Krell-Roesch; Ronald C Petersen; Yonas E Geda
Journal:  Harv Rev Psychiatry       Date:  2015 Sep-Oct       Impact factor: 3.732

Review 5.  DSM Nosology Changes in Neuropsychological Diagnoses through the Years: A Look at ADHD and Mild Neurocognitive Disorder.

Authors:  Anne R Carlew; Andrea L Zartman
Journal:  Behav Sci (Basel)       Date:  2016-12-29

6.  Evaluation of a research diagnostic algorithm for DSM-5 neurocognitive disorders in a population-based cohort of older adults.

Authors:  Ranmalee Eramudugolla; Moyra E Mortby; Perminder Sachdev; Chantal Meslin; Rajeev Kumar; Kaarin J Anstey
Journal:  Alzheimers Res Ther       Date:  2017-03-04       Impact factor: 6.982

7.  Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer's Coordinating Centers volunteers.

Authors:  Elizabeth A Wise; Paul B Rosenberg; Constantine G Lyketsos; Jeannie-Marie Leoutsakos
Journal:  Alzheimers Dement (Amst)       Date:  2019-04-18

8.  The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration.

Authors:  Perminder S Sachdev; Darren M Lipnicki; Nicole A Kochan; John D Crawford; Anbupalam Thalamuthu; Gavin Andrews; Carol Brayne; Fiona E Matthews; Blossom C M Stephan; Richard B Lipton; Mindy J Katz; Karen Ritchie; Isabelle Carrière; Marie-Laure Ancelin; Linda C W Lam; Candy H Y Wong; Ada W T Fung; Antonio Guaita; Roberta Vaccaro; Annalisa Davin; Mary Ganguli; Hiroko Dodge; Tiffany Hughes; Kaarin J Anstey; Nicolas Cherbuin; Peter Butterworth; Tze Pin Ng; Qi Gao; Simone Reppermund; Henry Brodaty; Nicole Schupf; Jennifer Manly; Yaakov Stern; Antonio Lobo; Raúl Lopez-Anton; Javier Santabárbara
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

9.  Problems in Classifying Mild Cognitive Impairment (MCI): One or Multiple Syndromes?

Authors:  María Del Carmen Díaz-Mardomingo; Sara García-Herranz; Raquel Rodríguez-Fernández; César Venero; Herminia Peraita
Journal:  Brain Sci       Date:  2017-09-01

10.  Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's Disease.

Authors:  William L Herring; Ian Gopal Gould; Howard Fillit; Peter Lindgren; Fiona Forrestal; Robin Thompson; Peter Pemberton-Ross
Journal:  Neurol Ther       Date:  2021-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.